祥生醫療(688358.SH):已佈局超聲智能技術
格隆匯8月7日丨祥生醫療(688358.SH)在互動平臺表示,公司已佈局的超聲智能技術,可實現動態圖像識別、疾病自動檢測與測量、智能化診斷流程優化及多模態AI融合,建立了覆蓋設備研發-影像採集-診斷決策的智能化標準框架,打造 "精準篩查-智能診斷-個性康復"三位一體服務網絡。以“乳腺人工智能超聲機器人”爲例,該技術着眼於解決目前國內乳腺癌羣體性篩查困境,結合超聲、機器人和人工智能技術,實現大範圍的患者篩查入口,逐步形成從篩查到診斷與數據跟蹤管理的乳腺健康管理模式。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.